you are here:

Mirae Asset Healthcare Fund - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 21.699 -0.05%
    (as on 05th August, 2022)
Invest Now
Crisil Rank

Not Ranked

Rank not available for the fund
Risk-O-Meter
High

The fund has 99.68% investment in domestic equities of which 45.4% is in Large Cap stocks, 20.31% is in Mid Cap stocks, 8.23% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    S&P BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • S&P BSE Healthcare TRI : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 05th August, 2022)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 29-Jul-22 10116.10 1.16% - 1.27% 75/130
1 Month 05-Jul-22 10701.80 7.02% - 9.76% 112/130
3 Month 05-May-22 10213.70 2.14% - 3.82% 93/130
6 Month 04-Feb-22 9524.60 -4.75% - -1.75% 104/127
YTD 31-Dec-21 9025.50 -9.75% - -1.22% 108/126
1 Year 05-Aug-21 9254.90 -7.45% -7.45% 4.54% 110/121
2 Year 05-Aug-20 13484.30 34.84% 16.12% 28.75% 93/107
3 Year 05-Aug-19 22137.30 121.37% 30.30% 19.91% 4/102
Since Inception 02-Jul-18 21699.00 116.99% 20.82% 12.24% 9/139

SIP Returns (NAV as on 05th August, 2022)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 05-Aug-21 12000 11667.39 -2.77 % -5.1 %
2 Year 05-Aug-20 24000 25574.97 6.56 % 6.24 %
3 Year 05-Aug-19 36000 48450.25 34.58 % 20.27 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.|If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.

Portfolio (Updated on 30th Jun,2022)

Portfolio Turnover Ratio : 27.00%  |   Category average turnover ratio is 164.48%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 99.68% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 99.68%
No of Stocks : 28 (Category Avg - 37.14) | Large Cap Investments : 45.4%| Mid Cap Investments : 20.31% | Small Cap Investments : 8.23% | Other : 25.77%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 2587.6 15.89% 0.04% 16.17% (Apr 2022) 12.69% (Jul 2021) 31.15 L 0.00
- Cipla Ltd. Pharmaceuticals 1491.4 9.16% -0.01% 9.16% (May 2022) 6.83% (Aug 2021) 16.26 L 64.70 k
Dr. Reddys Laboratories Ltd. Pharmaceuticals 1319.7 8.10% -0.83% 9.18% (Mar 2022) 7.46% (Jul 2021) 3.00 L -0.46 L
Apollo Hospitals Enterprises Ltd. Hospital 1072.6 6.59% -0.26% 8.7% (Nov 2021) 6.06% (Jul 2021) 2.91 L 0.00
Torrent Pharmaceuticals Ltd. Pharmaceuticals 1004.5 6.17% 0.29% 6.17% (Jun 2022) 4.94% (Jan 2022) 3.51 L 0.00
Ipca Laboratories Ltd. Pharmaceuticals 719.5 4.42% -0.34% 5.23% (Mar 2022) 3.84% (Jul 2021) 8.02 L -0.90 L
Krishna Institute of Medical Sciences Ltd. Hospital 693.7 4.26% 0.54% 4.26% (Jun 2022) 2.52% (Jul 2021) 5.86 L 1.06 L
Aurobindo Pharma Ltd. Pharmaceuticals 661.7 4.06% 0.13% 5.48% (Jul 2021) 2.31% (Nov 2021) 12.90 L 35.00 k
Gland Pharma Ltd. Pharmaceuticals 653.7 4.01% 0.24% 4.01% (Jun 2022) 3.15% (Sep 2021) 2.42 L 18.99 k
J.b. Chemicals & Pharmaceuticals Ltd. Pharmaceuticals 629 3.86% 0.34% 3.86% (Jun 2022) 2.64% (Jul 2021) 4.00 L 33.11 k
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 0.28%
Net Receivables Net Receivables 0.03%
MF Units MF Units 0.01%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 29th July, 2022)

  • Standard Deviation

    Low volatility
    18.85vs19.44
    Category Avg
  • Beta

    High volatility
    0.91vs0.75
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.2vs0.61
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.25vs0.16
    Category Avg
  • Jension's Alpha

    Better risk adjusted returns
    6.65vs2.25
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
UTI Transportation and Logistics Fund - Growth NA 1739.64 9.94 16.59 10.90 24.47 23.94
Aditya Birla Sun Life Commodity Equities Fund - Regular Plan - Global Agri Plan - Growth NA 16.04 7.94 -5.92 8.72 23.83 15.89
ICICI Prudential FMCG Fund - Growth NA 789.68 6.17 11.55 12.19 23.64 16.89
SBI Consumption Opportunities Fund - Regular Plan - Growth NA 918.84 7.23 3.34 4.34 22.09 23.56
ICICI Prudential Bharat Consumption Fund - Growth NA 1743.97 6.85 9.75 6.92 21.04 19.63
Quant ESG Equity Fund - Regular Plan - Growth NA 77.97 11.26 2.99 4.04 20.52 0.00
Quant Infrastructure Fund - Growth NA 539.75 11.52 2.31 -3.14 20.07 38.28
ICICI Prudential India Opportunities Fund - Growth NA 4781.24 10.34 4.83 3.15 19.99 24.88
ICICI Prudential Infrastructure Fund - Growth 2 1826.06 9.51 2.93 3.38 19.17 22.49
Nippon India Consumption Fund - Growth NA 194.80 9.84 11.44 8.36 17.16 26.71

More Funds from Mirae Asset Mutual Fund

Out of 34 mutual fund schemes offered by this AMC, 3 is/are ranked 4 * , 10 is/are ranked 3 * , 1 is/are ranked 1 * , and 20 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Mirae Asset Large Cap Fund - Regular - Growth 4 30299.43 8.19 4.41 -2.06 4.37 17.00
Mirae Asset Emerging Bluechip Fund - Growth 3 20663.71 8.99 4.43 -2.94 3.19 23.87
Mirae Asset Tax Saver Fund - Regular Plan - Growth 4 11494.59 8.62 3.65 -2.63 3.85 22.19
Mirae Asset Focused Fund - Growth 4 8061.98 7.13 2.52 -6.09 1.81 22.41
Mirae Asset Midcap Fund - Regular Plan - Growth NA 7173.23 11.53 5.98 1.32 8.58 29.27
Mirae Asset Hybrid - Equity - Growth 3 6395.79 7.34 3.81 -1.26 3.32 15.30
Mirae Asset Cash Management Fund - Growth 3 3472.48 0.39 1.16 2.03 3.72 4.04
Mirae Asset Great Consumer Fund - Growth NA 1649.14 10.81 9.43 4.75 13.19 21.82
Mirae Asset Healthcare Fund - Growth NA 1628.78 7.02 2.14 -4.75 -7.45 30.30
Mirae Asset Banking and Financial Services Fund - Growth NA 985.10 11.28 8.15 -2.06 2.75 0.00

Forum

+ See More